Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Johnson & Johnson Seeks U.S. and EU Approval for Subcutaneous DARZALEX® in High-Risk Smouldering Multiple Myeloma
Monday, November 11, 2024Johnson Johnson has submitted regulatory applications to both the US Food and Drug Administration FDA and the European Medicines Agency EMA for a new indication for DARZALEX FASPRO daratumumab and hyaluronidasefihj in the US and DARZALEX subcutaneou...
Alteogen Enters into Agreement with Daiichi Sankyo for ENHERTU® Development Using Hybrozyme™ Technology
Monday, November 11, 2024Alteogen has announced an exclusive licensing agreement with Daiichi Sankyo granting the latter global rights to leverage ALTB Alteogens innovative hyaluronidase created with Hybrozyme Technology
Aditum Bio and Leads Biolabs Join Forces to Develop New Autoimmune Disease Treatment
Friday, November 08, 2024Aditum Bio and Leads Biolabs have joined forces to establish Oblenio Bio a novel trispecific Tcell engager antibody for autoimmune diseases LBL is designed to target both CD and BCMA two key proteins involved in autoimmune diseases
Clearside Biomedical Signs Agreement with Santen Pharmaceutical for Eye Disease Treatment
Friday, November 08, 2024Clearside Biomedical announced a collaboration agreement between its AsiaPacific partner Arctic Vision and Santen Pharmaceutical Clearsides proprietary SCS injection approach delivers medication to the back of the eye a location crucial for treating...
Cumberland Pharmaceuticals Secures Orphan Drug and Rare Pediatric Disease Designations for Ifetroban
Thursday, November 07, 2024Cumberland Pharmaceuticals has announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation and Rare Pediatric Disease Designation to Ifetroban for the treatment of cardiomyopathy associated with Duchenne muscular dystro...
Leads Biolabs Gains FDA Orphan Drug Status for Innovative Antibody LBL-034 to Treat Multiple Myeloma
Thursday, November 07, 2024Leads Biolabs announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation ODD to LBL LBL is a humanized bispecific Tcell engaging antibody independently developed by Leads Biolabs to treat multiple myeloma MM
Nxera and Antiverse Partner to Develop Novel GPCR Antibody Therapies Using AI
Wednesday, November 06, 2024Nxera Pharma and Antiverse have joined forces to develop novel antibody therapies targeting Gprotein coupled receptors GPCRs using artificial intelligence This collaboration leverages Antiverses advanced generative AI technology including its proprie...
Inocras and Summit Pharmaceuticals Partner to Advance Genomic Medicine in Japan
Wednesday, November 06, 2024Inocras and Summit Pharmaceuticals have announced a strategic partnership to introduce advanced wholegenome sequencing WGS analysis services to the Japanese healthcare market
NJ Bio and Charles River Forge Strategic Alliance to Advance ADC Development and Manufacturing
Wednesday, November 06, 2024NJ Bio and Charles River Laboratories have announced a strategic partnership to offer comprehensive services for the development and manufacturing of antibodydrug conjugates ADCs
Ring Therapeutics Enters into Partnerships with A*STAR and SERI to Boost Gene Therapy Research in Singapore
Tuesday, November 05, 2024Ring Therapeutics has announced strategic partnerships with Agency for Science Technology and Research ASTAR and the Singapore Eye Research Institute SERI
